Use of rhodamine 6g as a medicinal agent for treating malignant neoplasms and amiloidoses
OwnerMikhail Kutushovinventor
Life of this patent
Estimating the term…
Abstract
Rhodamine 6G is used as a medical agent for treating malignant neoplasms and amyloidoses at a dosage ranging from 1 mg to 10 g in the form of an aqueous, physiological, or alcoholic solution. For different purposes, the rhodamine G6 solution is orally administered before or after meals, or rhodamine G6 solution is rectally administered or the rhodamine G6 1% solution is intravenously injected, or the rhodamine G6 is administered in the form if a suppository or a 1-5% ointment.
Claims8
A method of treating a disorder selected from malignant neoplasms and amyloidoses in a subject, comprising the step of administering to said subject rhodamine 6G in a dosage ranging from 1 mg to 10 g.
Dependencies are inferred from the claim text.